Progyny Balanced Scorecard
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Explore the Complete Growth Strategy Behind the Preview
This Progyny Balanced Scorecard Analysis gives you a structured view of the company's financial, customer, internal process, and learning and growth priorities. This page already includes a real preview of the analysis, so you can review the actual content and format before buying. Purchase the full version to get the complete ready-to-use report.
Benefits
Outcome Fit
Outcome Fit is strong for Progyny because its model is built on better clinical results and lower total spend, not just revenue. A Balanced Scorecard keeps outcome, cost, and member trust in view, which matters in fertility care where 1 in 6 adults face infertility and a single IVF cycle can cost about $15,000 to $25,000. That makes quality a buying driver, not a nice-to-have.
Cost Discipline
Cost Discipline is clear when Progyny can show guided care cutting avoidable spend in a 1,000-member employer book, where fertility treatment can run $15,000 to $25,000 per cycle before drugs. Its integrated pharmacy benefit links treatment choice, medication use, and total cost in one view, so savings are easier to test against actual claims. That gives employers and health plans a cleaner read on whether they are paying for better outcomes, not just more care.
Renewal Proof
Renewal proof shows whether employer clients keep Progyny after the first contract, and that is the cleanest sign the program is working. In FY2025, the best test is not new sales alone but whether clients renew and expand, which signals product-market fit in fertility and women's health benefits. Strong renewal behavior also helps explain why recurring revenue matters so much: it turns client satisfaction into a durable base for future growth.
Member Trust
Member trust is a key Balanced Scorecard lens for Progyny because fertility care is personal, and members judge value by support, not just price. Track satisfaction, ease of navigation, and confidence in care delivery across IVF, egg freezing, and adoption paths. Strong trust should show up in higher retention, faster care starts, and fewer member escalations.
Care Quality
Care quality is where Progyny's steerage strategy should show up in the numbers: if higher-quality providers lift treatment success and cut avoidable delays, the scorecard should reflect it. Management can track 2025-style measures like referral completion, time to care, and cycle success to see whether members are reaching the right clinics faster and with better outcomes. That gives a cleaner read on provider selection than raw utilization alone.
Progyny Wins When Fertility Care Delivers Better Outcomes
Benefits are strongest when Progyny turns costly fertility care into a guided, high-trust service with clearer outcomes. In FY2025, that matters because 1 in 6 adults face infertility, and a single IVF cycle can cost about $15,000 to $25,000, so employer value depends on better care, not just access. Renewals and member satisfaction are the main proof points.
| Metric | FY2025 lens |
|---|---|
| Infertility rate | 1 in 6 adults |
| IVF cycle cost | $15,000-$25,000 |
| Benefit signal | Renewals and trust |
What is included in the product
Detailed Word Document
Editable Excel File
Drawbacks
Lagging Signals
Lagging signals are a real weakness in Progyny Balanced Scorecard Analysis because fertility outcomes often need several steps and weeks to show up. That makes the scorecard slow for sales, implementation, and early member engagement feedback, so teams may see the result only after the spend is already booked. In a 2025 review, that delay can hide cost pressure for 1 quarter or more, which weakens fast course correction.
Data Silos
Data silos are a real weakness for Progyny because the scorecard pulls from employers, health plans, providers, and pharmacies. In FY2025, that kind of multi-feed setup can leave metrics out of sync, so results look noisy or lagged even when the program is working well. The bigger the account mix, the harder it is to compare outcomes cleanly across clients. That can blur readouts on cost, utilization, and cycle time.
Attribution Noise
In FY2025, Progyny's scorecard can show a better cycle result, but that still may hide whether the driver was provider quality, member mix, benefit design, or pharmacy adherence. With thousands of covered members moving through different clinics and plans, small shifts in case complexity can change outcome rates without proving causation. So attribution noise means the scorecard tracks correlation well, but it cannot cleanly isolate what caused the win.
Emotional Blind Spot
An emotional blind spot is a real drawback because a scorecard can track spend, cycles, and utilization, but miss stress, trust, and empathy, which shape fertility care. The World Health Organization says about 1 in 6 adults face infertility, so the human side is not a side issue. That means Progyny can show value in dollars and access, yet still give only a partial read on member experience.
Client Variation
Employer groups vary a lot by age, region, plan rules, and fertility demand, so one balanced scorecard can blur the real driver of results. For Progyny, that means a high-cost client with older members and broader coverage can look worse than a younger, tighter-coverage client, even if service quality is stronger. This can skew customer-to-customer and year-to-year comparisons and make a 1% swing look like a performance change when it is really mix shift.
- Mix can mask true client quality.
- Coverage rules change the cost base.
Progyny Scorecard: strong data, but FY2025 decisions may lag
Progyny's Balanced Scorecard can lag by 1 quarter or more, so FY2025 decisions may come after spend is locked. Multi-feed data from employers, plans, clinics, and pharmacies can drift out of sync, and mix shifts across client groups can blur true performance. It also tracks cost and cycles well but misses stress and trust; WHO says about 1 in 6 adults face infertility.
| Drawback | FY2025 impact |
|---|---|
| Lag and silos | 1 quarter+ delay |
Get Your Copy
Progyny Reference Sources
This preview shows the actual Progyny Balanced Scorecard Analysis document you'll receive after purchase – no sample, no placeholders. The full version is the same professional report, complete with detailed insights and structured analysis. Unlock the complete file immediately after checkout.
Frequently Asked Questions
It measures whether Progyny is improving fertility outcomes while lowering employer healthcare costs. A practical scorecard would track at least 3 core indicators: clinical success rates, client renewal or retention, and per-member cost trend. Because the company also supports IVF, egg freezing, and adoption, member satisfaction and provider quality should sit alongside the financial metrics.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.